(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Marathon, Riot Blockchain, and Arcturus Therapeutics.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Marathon (MARA) 69.68 9.18% 2021-11-08 07:09:32
2 Riot Blockchain (RIOT) 33.70 7.02% 2021-11-08 07:12:37
3 Arcturus Therapeutics (ARCT) 39.65 6.02% 2021-11-08 05:11:15
4 MicroStrategy (MSTR) 843.00 5.7% 2021-11-08 07:09:41
5 Canaan (CAN) 9.22 5.61% 2021-11-08 07:11:34
6 Vulcan Materials Company (VMC) 205.04 4.58% 2021-11-08 07:19:56
7 Caterpillar (CAT) 215.00 4.43% 2021-11-08 07:16:44
8 United Rentals (URI) 409.00 4.35% 2021-11-08 07:19:50
9 Regeneron Pharmaceuticals (REGN) 637.59 4.26% 2021-11-08 07:10:17
10 Nucor Corporation (NUE) 116.98 4.26% 2021-11-08 07:18:53

The three most active and biggest losers today are Tesla, Ulta Beauty, and Moderna.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Tesla (TSLA) 1152.22 -5.72% 2021-11-08 07:10:45
2 Ulta Beauty (ULTA) 370.70 -5.4% 2021-11-08 06:10:58
3 Moderna (MRNA) 228.18 -3.72% 2021-11-08 07:12:15
4 Peloton (PTON) 53.64 -3.59% 2021-11-08 07:12:32
5 Smith & Nephew (SNN) 36.31 -2.26% 2021-11-08 07:19:28
6 FibroGen (FGEN) 12.89 -1.98% 2021-11-08 04:08:24
7 NXP Semiconductors (NXPI) 220.00 -1.9% 2021-11-08 07:09:59
8 Fresenius Medical Care AG (FMS) 34.89 -1.69% 2021-11-08 07:17:42
9 Hartford Financial Services Group (HIG) 70.70 -1.57% 2021-11-08 04:15:23
10 DISH Network (DISH) 37.31 -1.45% 2021-11-08 04:08:01

Most Active Premarket Winners today

1. Marathon (MARA) – Premarket: 9.18%

NASDAQ Composite ended the session with Marathon dropping 0.73% to $63.82 on Monday while NASDAQ Composite jumped 0.2% to $15,971.59.

Volume

Today’s last reported volume for Marathon is 7349490, 32.81% below its average volume of 10939600.

Marathon’s last close was $64.29, 2.25% under its 52-week high of $65.77.

Marathon’s Revenue

Year-on-year quarterly revenue growth grew by 1444.8%, now sitting on 12.92M for the twelve trailing months.

Volatility

Marathon’s last week, last month’s, and last quarter’s current volatility was 5.20%, 2.71%, and 5.04%, respectively.

Marathon’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.59% (last week), 5.24% (last month), and 5.04% (last quarter), respectively.

Marathon’s Stock Yearly Top and Bottom Value

Marathon’s stock is valued at $63.82 at 07:34 EST, under its 52-week high of $65.77 and way above its 52-week low of $2.06.

Marathon’s Moving Average

Marathon’s value is way higher than its 50-day moving average of $44.08 and way higher than its 200-day moving average of $33.75.

Previous days news about Marathon

  • New York marathon: the big Apple is back and cannabis came with it. According to Benzinga on Saturday, 6 November, "Kerin Hempel, chief executive of the New York Road Runners, the organization that operates the marathon, said this Marathon brings back a sense of normalcy to the city, which is ready to welcome tourists, and their dollars, back to the Big Apple."

More news about Marathon.

2. Riot Blockchain (RIOT) – Premarket: 7.02%

NASDAQ Composite ended the session with Riot Blockchain dropping 3.76% to $31.49 on Monday, following the last session’s downward trend. NASDAQ Composite jumped 0.2% to $15,971.59, after five sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Riot Blockchain is 8801280, 23.68% below its average volume of 11533000.

Riot Blockchain’s last close was $32.72, 58.84% below its 52-week high of $79.50.

The company’s growth estimates for the current quarter and the next is 700% and 125%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 1668.7%, now sitting on 65.3M for the twelve trailing months.

Volatility

Riot Blockchain’s last week, last month’s, and last quarter’s current volatility was 5.38%, 1.29%, and 4.23%, respectively.

Riot Blockchain’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.46% (last week), 4.61% (last month), and 4.23% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Riot Blockchain’s stock is considered to be oversold (<=20).

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $31.49 at 07:34 EST, way under its 52-week high of $79.50 and way higher than its 52-week low of $3.20.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is way higher than its 50-day moving average of $27.98 and under its 200-day moving average of $31.57.

More news about Riot Blockchain.

3. Arcturus Therapeutics (ARCT) – Premarket: 6.02%

NASDAQ Composite ended the session with Arcturus Therapeutics sliding 16.39% to $37.40 on Monday, after three successive sessions in a row of losses. NASDAQ Composite jumped 0.2% to $15,971.59, after five consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Arcturus Therapeutics is 1167100, 82.09% above its average volume of 640921.

Arcturus Therapeutics’s last close was $44.73, 65.52% below its 52-week high of $129.71.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.

Volatility

Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 1.76%, a positive 0.46%, and a positive 3.46%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.76% (last week), 2.38% (last month), and 3.46% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $37.40 at 07:34 EST, way below its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way below its 50-day moving average of $46.58 and under its 200-day moving average of $40.32.

More news about Arcturus Therapeutics.

4. MicroStrategy (MSTR) – Premarket: 5.7%

NASDAQ Composite ended the session with MicroStrategy falling 0.31% to $797.51 on Monday, following the last session’s downward trend. NASDAQ Composite rose 0.2% to $15,971.59, after five successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for MicroStrategy is 543475, 19.06% below its average volume of 671456.

MicroStrategy’s last close was $800.00, 39.16% under its 52-week high of $1,315.00.

The company’s growth estimates for the ongoing quarter and the next is 183.8% and 282.1%, respectively.

MicroStrategy’s Revenue

Year-on-year quarterly revenue growth grew by 13.4%, now sitting on 506.98M for the twelve trailing months.

Volatility

MicroStrategy’s last week, last month’s, and last quarter’s current volatility was 2.88%, 0.66%, and 3.04%, respectively.

MicroStrategy’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.73% (last week), 2.52% (last month), and 3.04% (last quarter), respectively.

MicroStrategy’s Stock Yearly Top and Bottom Value

MicroStrategy’s stock is valued at $797.51 at 07:34 EST, way under its 52-week high of $1,315.00 and way higher than its 52-week low of $177.50.

MicroStrategy’s Moving Average

MicroStrategy’s worth is way above its 50-day moving average of $682.82 and way above its 200-day moving average of $627.08.

More news about MicroStrategy.

5. Canaan (CAN) – Premarket: 5.61%

NASDAQ Composite ended the session with Canaan dropping 6.03% to $8.73 on Monday, following the last session’s upward trend. NASDAQ Composite jumped 0.2% to $15,971.59, after five successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Canaan is 5584280, 21.98% below its average volume of 7157760.

Canaan’s last close was $9.29, 76.24% below its 52-week high of $39.10.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 507.3%, now sitting on 447.69M for the twelve trailing months.

Volatility

Canaan’s last week, last month’s, and last quarter’s current volatility was 1.26%, 2.22%, and 5.80%, respectively.

Canaan’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.92% (last week), 5.05% (last month), and 5.80% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Canaan’s stock is considered to be oversold (<=20).

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $8.73 at 07:34 EST, way under its 52-week high of $39.10 and way higher than its 52-week low of $2.29.

Canaan’s Moving Average

Canaan’s value is way higher than its 50-day moving average of $7.40 and higher than its 200-day moving average of $8.65.

More news about Canaan.

6. Vulcan Materials Company (VMC) – Premarket: 4.58%

NYSE Composite ended the session with Vulcan Materials Company rising 1.07% to $196.06 on Monday, after two consecutive sessions in a row of losses. NYSE Composite jumped 0.43% to $17,242.36, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Vulcan Materials Company is 665299, 19.05% below its average volume of 821889.

Vulcan Materials Company’s last close was $193.98, 3.23% below its 52-week high of $200.46.

Vulcan Materials Company’s Sales

Vulcan Materials Company’s sales growth is 10.8% for the current quarter and 13.6% for the next. The company’s growth estimates for the present quarter and the next is 9% and 8.4%, respectively.

Vulcan Materials Company’s Revenue

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 4.91B for the twelve trailing months.

Volatility

Vulcan Materials Company’s last week, last month’s, and last quarter’s current volatility was 1.03%, 0.51%, and 1.40%, respectively.

Vulcan Materials Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.39% (last week), 1.48% (last month), and 1.40% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Vulcan Materials Company’s stock is considered to be overbought (>=80).

Vulcan Materials Company’s Stock Yearly Top and Bottom Value

Vulcan Materials Company’s stock is valued at $196.06 at 07:34 EST, under its 52-week high of $200.46 and way higher than its 52-week low of $132.85.

Vulcan Materials Company’s Moving Average

Vulcan Materials Company’s value is above its 50-day moving average of $179.15 and above its 200-day moving average of $179.96.

More news about Vulcan Materials Company.

7. Caterpillar (CAT) – Premarket: 4.43%

NYSE Composite ended the session with Caterpillar jumping 1.12% to $205.88 on Monday while NYSE Composite rose 0.43% to $17,242.36.

Volume

Today’s last reported volume for Caterpillar is 2276020, 34.03% below its average volume of 3450230.

Caterpillar’s last close was $203.59, 17.47% below its 52-week high of $246.69.

Caterpillar’s Sales

Caterpillar’s sales growth is 27.1% for the present quarter and 16.6% for the next. The company’s growth estimates for the ongoing quarter and the next is 70.1% and 13.2%, respectively.

Caterpillar’s Revenue

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 43B for the twelve trailing months.

Volatility

Caterpillar’s last week, last month’s, and last quarter’s current volatility was a negative 0.29%, a positive 0.23%, and a positive 1.39%, respectively.

Caterpillar’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.87% (last week), 1.31% (last month), and 1.39% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Caterpillar’s stock is considered to be overbought (>=80).

Caterpillar’s Stock Yearly Top and Bottom Value

Caterpillar’s stock is valued at $205.88 at 07:34 EST, way under its 52-week high of $246.69 and way higher than its 52-week low of $160.76.

Caterpillar’s Moving Average

Caterpillar’s worth is higher than its 50-day moving average of $197.75 and below its 200-day moving average of $214.83.

More news about Caterpillar.

8. United Rentals (URI) – Premarket: 4.35%

NYSE Composite ended the session with United Rentals jumping 1.55% to $391.96 on Monday while NYSE Composite jumped 0.43% to $17,242.36.

Volume

Today’s last reported volume for United Rentals is 470208, 17.05% below its average volume of 566892.

United Rentals’s last close was $385.97, 2.74% below its 52-week high of $396.84.

United Rentals’s Sales

United Rentals’s sales growth is 18.5% for the current quarter and 15.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 26.3% and 30%, respectively.

United Rentals’s Revenue

Year-on-year quarterly revenue growth grew by 17.9%, now sitting on 8.81B for the twelve trailing months.

Volatility

United Rentals’s last week, last month’s, and last quarter’s current volatility was 0.23%, 0.64%, and 1.64%, respectively.

United Rentals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.09% (last week), 1.61% (last month), and 1.64% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

United Rentals’s stock is considered to be oversold (<=20).

United Rentals’s Stock Yearly Top and Bottom Value

United Rentals’s stock is valued at $391.96 at 07:34 EST, below its 52-week high of $396.84 and way higher than its 52-week low of $187.98.

United Rentals’s Moving Average

United Rentals’s value is above its 50-day moving average of $356.46 and way higher than its 200-day moving average of $334.92.

More news about United Rentals.

9. Regeneron Pharmaceuticals (REGN) – Premarket: 4.26%

NASDAQ Composite ended the session with Regeneron Pharmaceuticals sliding 5.57% to $611.54 on Monday, following the last session’s downward trend. NASDAQ Composite rose 0.2% to $15,971.59, after five sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Regeneron Pharmaceuticals is 1768490, 114.3% above its average volume of 825214.

Regeneron Pharmaceuticals’s last close was $647.63, 5.68% below its 52-week high of $686.62.

Regeneron Pharmaceuticals’s Sales

Regeneron Pharmaceuticals’s sales growth is 28.6% for the ongoing quarter and 18.3% for the next. The company’s growth estimates for the present quarter and the next is 7.7% and 8%, respectively.

Regeneron Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 163.2%, now sitting on 12.2B for the twelve trailing months.

Volatility

Regeneron Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 0.45%, 0.88%, and 1.43%, respectively.

Regeneron Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.95% (last week), 1.35% (last month), and 1.43% (last quarter), respectively.

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $611.54 at 07:34 EST, way below its 52-week high of $686.62 and way above its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s value is above its 50-day moving average of $595.40 and above its 200-day moving average of $573.21.

More news about Regeneron Pharmaceuticals.

10. Nucor Corporation (NUE) – Premarket: 4.26%

NYSE Composite ended the session with Nucor Corporation rising 0.36% to $112.20 on Monday, after two consecutive sessions in a row of gains. NYSE Composite jumped 0.43% to $17,242.36, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Nucor Corporation is 3098790, 12.55% below its average volume of 3543560.

Nucor Corporation’s last close was $111.80, 13.21% below its 52-week high of $128.81.

Nucor Corporation’s Sales

Nucor Corporation’s sales growth is 99.4% for the present quarter and 71.8% for the next. The company’s growth estimates for the present quarter and the next is 884.6% and 345.7%, respectively.

Nucor Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 103.1%, now sitting on 25.99B for the twelve trailing months.

Volatility

Nucor Corporation’s last week, last month’s, and last quarter’s current volatility was 0.79%, 0.71%, and 2.31%, respectively.

Nucor Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.04% (last week), 1.77% (last month), and 2.31% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Nucor Corporation’s stock is considered to be oversold (<=20).

Nucor Corporation’s Stock Yearly Top and Bottom Value

Nucor Corporation’s stock is valued at $112.20 at 07:34 EST, way below its 52-week high of $128.81 and way higher than its 52-week low of $47.94.

Nucor Corporation’s Moving Average

Nucor Corporation’s value is higher than its 50-day moving average of $102.83 and higher than its 200-day moving average of $102.22.

More news about Nucor Corporation.

Most Active Premarket Losers Today

1. Tesla (TSLA) – Premarket: -5.72%

NASDAQ Composite ended the session with Tesla dropping 0.64% to $1,222.09 on Monday, after two sequential sessions in a row of gains. NASDAQ Composite jumped 0.2% to $15,971.59, after five sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Tesla is 21628800, 0.33% above its average volume of 21557400.

Tesla’s last close was $1,229.91, 1.09% under its 52-week high of $1,243.49.

Tesla’s Sales

Tesla’s sales growth is 49.9% for the ongoing quarter and 37.7% for the next. The company’s growth estimates for the current quarter and the next is 81.6% and 102.5%, respectively.

Tesla’s Revenue

Year-on-year quarterly revenue growth grew by 73.6%, now sitting on 35.94B for the twelve trailing months.

Volatility

Tesla’s last week, last month’s, and last quarter’s current volatility was 0.59%, 2.44%, and 1.89%, respectively.

Tesla’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.67% (last week), 2.90% (last month), and 1.89% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tesla’s stock is considered to be oversold (<=20).

Tesla’s Stock Yearly Top and Bottom Value

Tesla’s stock is valued at $1,222.09 at 07:34 EST, under its 52-week high of $1,243.49 and way above its 52-week low of $396.03.

Tesla’s Moving Average

Tesla’s value is way higher than its 50-day moving average of $879.48 and way higher than its 200-day moving average of $721.54.

Previous days news about Tesla

  • Why lucid CEO sees Tesla 4680 batteries being A 'huge breakthrough' as just A 'fantasy'. According to Benzinga on Friday, 5 November, "Lucid Group Inc (NASDAQ: LCID) CEO Peter Rawlinson believes Tesla Inc’s (NASDAQ: TSLA) new 4680-type cylindrical cell format is not a "huge breakthrough," IEEE spectrum reported, citing the executive.", "The former Tesla employee said the benefits include reduced internal resistance and higher energy density and that’s a "valuable step forward."
  • Tesla surpasses a whole index worth of energy industry leaders. According to Bloomberg Quint on Friday, 5 November, "And though Tesla currently has less influence on the index than the energy sector, that conceivably could change if the stock continues to climb."
  • Twitter users tell Elon Musk to sell 10% of his Tesla stake. According to MarketWatch on Sunday, 7 November, " Wedbush analysts Dan Ives and John Katsingris lifted their Tesla bull case to $1,800 a share from $1,500, in a note to clients that published Sunday. ", "Elon wants the stock lower for good reasons," said Tesla investor Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, in emailed comments. "
  • Elon Musk proposes selling 10% of his Tesla stock in a twitter poll. According to Business Insider on Saturday, 6 November, "Billionaire Elon Musk on Saturday asked his Twitter followers to decide whether he should sell 10% of his Tesla stock, promising to "abide by the results of this poll, whichever way it goes.", "Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock," the electric car maker’s CEO said. "

More news about Tesla.

2. Ulta Beauty (ULTA) – Premarket: -5.4%

NASDAQ Composite ended the session with Ulta Beauty rising 2.83% to $391.85 on Monday, following the last session’s downward trend. NASDAQ Composite jumped 0.2% to $15,971.59, after five successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Ulta Beauty is 590884, 19.21% below its average volume of 731403.

Ulta Beauty’s last close was $381.07, 8.17% below its 52-week high of $414.98.

The company’s growth estimates for the current quarter and the next is 40.2% and 16.1%, respectively.

Ulta Beauty’s Revenue

Year-on-year quarterly revenue growth grew by 60.2%, now sitting on 7.66B for the twelve trailing months.

Volatility

Ulta Beauty’s last week, last month’s, and last quarter’s current volatility was 1.44%, 0.10%, and 1.35%, respectively.

Ulta Beauty’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.57% (last week), 1.83% (last month), and 1.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ulta Beauty’s stock is considered to be oversold (<=20).

Ulta Beauty’s Stock Yearly Top and Bottom Value

Ulta Beauty’s stock is valued at $391.85 at 07:34 EST, below its 52-week high of $414.98 and way above its 52-week low of $210.01.

Ulta Beauty’s Moving Average

Ulta Beauty’s value is higher than its 50-day moving average of $376.66 and way higher than its 200-day moving average of $352.10.

More news about Ulta Beauty.

3. Moderna (MRNA) – Premarket: -3.72%

NASDAQ Composite ended the session with Moderna dropping 16.56% to $236.99 on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite jumped 0.2% to $15,971.59, after five sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Moderna is 59195700, 287.69% above its average volume of 15268600.

Moderna’s last close was $284.02, 42.91% below its 52-week high of $497.49.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the current quarter and 1202.8% for the next. The company’s growth estimates for the present quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was a negative 6.39%, a negative 0.46%, and a positive 4.12%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.66% (last week), 3.24% (last month), and 4.12% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $236.99 at 07:34 EST, way under its 52-week high of $497.49 and way above its 52-week low of $70.87.

Moderna’s Moving Average

Moderna’s value is way below its 50-day moving average of $356.46 and way under its 200-day moving average of $294.34.

Previous days news about Moderna

  • Moderna cedes S&P’s top-performer crown after record stock swoon. According to Bloomberg Quint on Friday, 5 November, "With Moderna trading at levels only seen before its S&P inclusion, Singh, who rates the stock a hold-equivalent, expects a rebound if it’s able to show a quarter or two of improving sales and an upbeat 2022 forecast."

More news about Moderna.

4. Peloton (PTON) – Premarket: -3.59%

NASDAQ Composite ended the session with Peloton sliding 35.35% to $55.64 on Monday while NASDAQ Composite rose 0.2% to $15,971.59.

Volume

Today’s last reported volume for Peloton is 82779200, 1034.41% above its average volume of 7297120.

Peloton’s last close was $86.06, 49.7% below its 52-week high of $171.09.

The company’s growth estimates for the present quarter and the next is a negative 630% and a negative 438.9%, respectively.

Peloton’s Revenue

Year-on-year quarterly revenue growth grew by 54.3%, now sitting on 4.02B for the twelve trailing months.

Volatility

Peloton’s last week, last month’s, and last quarter’s current volatility was a negative 2.58%, a negative 0.01%, and a positive 2.66%, respectively.

Peloton’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.97% (last week), 2.28% (last month), and 2.66% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Peloton’s stock is considered to be overbought (>=80).

Peloton’s Stock Yearly Top and Bottom Value

Peloton’s stock is valued at $55.64 at 07:34 EST, under its 52-week low of $55.78.

Peloton’s Moving Average

Peloton’s worth is way under its 50-day moving average of $90.44 and way under its 200-day moving average of $104.28.

Previous days news about Peloton

  • Peloton turns from lockdown darling to ‘mispriced’ growth stock. According to Bloomberg Quint on Friday, 5 November, "For some investors the selloff in Peloton and other pandemic winners is a welcome adjustment to valuations.", "The answer is clear at least on Wall Street, with Peloton Interactive Inc.’s stock plunging after the at-home fitness company’s dismal earnings. "
  • Tesla, Peloton, AMD are seeing high wallstreetbets interest today but this stock is at the top of the chart. According to Benzinga on Friday, 5 November, "Nvidia Corp. (NASDAQ:NVDA) has emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum as of Thursday night, while Tesla Inc. (NASDAQ:TSLA), Peloton Interactive Inc. (NASDAQ:PTON), Advanced Micro Devices Inc. (NASDAQ:AMD) and GameStop Corp. (NYSE:GME) are also seeing high interest.", "Exchange-traded fund SPDR S&P 500 ETF Trust (NYSE:SPY) andfitness products maker Peloton Interactive are in the third and fourth positions, having attracted 456 and 443 mentions, respectively."
  • 6 Peloton analysts break down Q1 earnings: 'not the year we envisioned'. According to Business Insider on Friday, 5 November, "KeyBanc analyst Edward Yruma said Peloton has set a low bar for fiscal 2022 ahead of potential new device launches.", "Needham analyst Bernie McTernan said upside for Peloton will hinge on its growth trajectory in fiscal 2023 and beyond."
  • Peloton CEO falls out of billionaire ranks as bike-maker plunges. According to Bloomberg Quint on Friday, 5 November, "More than two-thirds of Foley’s wealth consists of options that give him the right to purchase more Peloton stock over time. ", "Altogether he has sold almost $120 million in Peloton stock, according to Bloomberg calculations. "
  • Peloton interactive (pton) stock news and forecast: why is Peloton stock falling today?. According to FXStreet on Friday, 5 November, "This appears to have been the case for the trend leader Peloton (symbol PTON) who announced earnings after the close on Thursday. "

More news about Peloton.

5. Smith & Nephew (SNN) – Premarket: -2.26%

NYSE Composite ended the session with Smith & Nephew rising 3.95% to $37.15 on Monday, after two sequential sessions in a row of gains. NYSE Composite rose 0.43% to $17,242.36, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Smith & Nephew is 942642, 141.9% above its average volume of 389675.

Smith & Nephew’s last close was $35.74, 22.47% below its 52-week high of $46.10.

Smith & Nephew’s Revenue

Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 4.56B for the twelve trailing months.

Volatility

Smith & Nephew’s last week, last month’s, and last quarter’s current volatility was 0.51%, 0.21%, and 1.12%, respectively.

Smith & Nephew’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.45% (last week), 1.04% (last month), and 1.12% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Smith & Nephew’s stock is considered to be oversold (<=20).

Smith & Nephew’s Stock Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $37.15 at 07:34 EST, way under its 52-week high of $46.10 and way above its 52-week low of $33.49.

Smith & Nephew’s Moving Average

Smith & Nephew’s worth is above its 50-day moving average of $35.40 and under its 200-day moving average of $39.88.

More news about Smith & Nephew.

6. FibroGen (FGEN) – Premarket: -1.98%

NASDAQ Composite ended the session with FibroGen jumping 2.02% to $13.15 on Monday, after four consecutive sessions in a row of gains. NASDAQ Composite jumped 0.2% to $15,971.59, after five sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for FibroGen is 974617, 18.8% below its average volume of 1200400.

FibroGen’s last close was $12.89, 77.47% under its 52-week high of $57.21.

FibroGen’s Sales

FibroGen’s sales growth is 201.9% for the ongoing quarter and 13.3% for the next. The company’s growth estimates for the current quarter is a negative 134.3% and positive 39.1% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current volatility was 3.39%, 1.20%, and 2.81%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.39% (last week), 2.95% (last month), and 2.81% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be oversold (<=20).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $13.15 at 07:34 EST, way under its 52-week high of $57.21 and way above its 52-week low of $9.88.

FibroGen’s Moving Average

FibroGen’s worth is way higher than its 50-day moving average of $10.92 and way under its 200-day moving average of $16.89.

More news about FibroGen.

7. NXP Semiconductors (NXPI) – Premarket: -1.9%

NASDAQ Composite ended the session with NXP Semiconductors jumping 2.28% to $224.25 on Monday, after five successive sessions in a row of gains. NASDAQ Composite rose 0.2% to $15,971.59, after five consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for NXP Semiconductors is 2811290, 34.81% above its average volume of 2085320.

NXP Semiconductors’s last close was $219.26, 4.14% below its 52-week high of $228.72.

NXP Semiconductors’s Sales

NXP Semiconductors’s sales growth is 27.1% for the present quarter and 16.1% for the next. The company’s growth estimates for the present quarter and the next is 68.5% and 27.9%, respectively.

NXP Semiconductors’s Revenue

Year-on-year quarterly revenue growth grew by 42.9%, now sitting on 9.94B for the twelve trailing months.

Volatility

NXP Semiconductors’s last week, last month’s, and last quarter’s current volatility was 2.26%, 0.76%, and 1.70%, respectively.

NXP Semiconductors’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.26% (last week), 1.66% (last month), and 1.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NXP Semiconductors’s stock is considered to be oversold (<=20).

NXP Semiconductors’s Stock Yearly Top and Bottom Value

NXP Semiconductors’s stock is valued at $224.25 at 07:34 EST, below its 52-week high of $228.72 and way above its 52-week low of $139.94.

NXP Semiconductors’s Moving Average

NXP Semiconductors’s worth is way higher than its 50-day moving average of $199.96 and way higher than its 200-day moving average of $202.42.

More news about NXP Semiconductors.

8. Fresenius Medical Care AG (FMS) – Premarket: -1.69%

NYSE Composite ended the session with Fresenius Medical Care AG rising 3.74% to $35.49 on Monday, following the last session’s upward trend. NYSE Composite rose 0.43% to $17,242.36, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 325325, 14.01% below its average volume of 378343.

Fresenius Medical Care AG’s last close was $34.21, 22.48% under its 52-week high of $44.13.

Fresenius Medical Care AG’s Sales

Fresenius Medical Care AG’s sales growth is a negative 5% for the ongoing quarter and 27.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 26% and a negative 24.7%, respectively.

Fresenius Medical Care AG’s Revenue

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Volatility

Fresenius Medical Care AG’s last week, last month’s, and last quarter’s current volatility was a positive 0.17%, a negative 0.14%, and a positive 1.10%, respectively.

Fresenius Medical Care AG’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.76% (last week), 1.21% (last month), and 1.10% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fresenius Medical Care AG’s stock is considered to be oversold (<=20).

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $35.49 at 07:34 EST, way below its 52-week high of $44.13 and higher than its 52-week low of $33.12.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s value is above its 50-day moving average of $35.10 and under its 200-day moving average of $38.85.

More news about Fresenius Medical Care AG.

9. Hartford Financial Services Group (HIG) – Premarket: -1.57%

NYSE Composite ended the session with Hartford Financial Services Group falling 0.15% to $71.83 on Monday while NYSE Composite rose 0.43% to $17,242.36.

Volume

Today’s last reported volume for Hartford Financial Services Group is 1481930, 21.63% below its average volume of 1890950.

Hartford Financial Services Group’s last close was $71.94, 7.97% below its 52-week high of $78.17.

Hartford Financial Services Group’s Sales

Hartford Financial Services Group’s sales growth is 1.6% for the current quarter and a decline by 0.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 2.1% and a negative 7.4%, respectively.

Hartford Financial Services Group’s Revenue

Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 21.35B for the twelve trailing months.

Volatility

Hartford Financial Services Group’s last week, last month’s, and last quarter’s current volatility was a negative 0.56%, a negative 0.13%, and a positive 0.95%, respectively.

Hartford Financial Services Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.74% (last week), 0.97% (last month), and 0.95% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Hartford Financial Services Group’s stock is considered to be overbought (>=80).

Hartford Financial Services Group’s Stock Yearly Top and Bottom Value

Hartford Financial Services Group’s stock is valued at $71.83 at 07:34 EST, below its 52-week high of $78.17 and way higher than its 52-week low of $39.30.

Hartford Financial Services Group’s Moving Average

Hartford Financial Services Group’s worth is above its 50-day moving average of $71.71 and above its 200-day moving average of $66.92.

More news about Hartford Financial Services Group.

10. DISH Network (DISH) – Premarket: -1.45%

NASDAQ Composite ended the session with DISH Network rising 2.1% to $37.86 on Monday while NASDAQ Composite jumped 0.2% to $15,971.59.

Volume

Today’s last reported volume for DISH Network is 3996220, 113.47% above its average volume of 1871980.

DISH Network’s last close was $37.08, 21.19% below its 52-week high of $47.05.

DISH Network’s Sales

DISH Network’s sales growth is 24.7% for the present quarter and a decline by 2.6% for the next. The company’s growth estimates for the ongoing quarter is 3.5% and a drop 39.2% for the next.

DISH Network’s Revenue

Year-on-year quarterly revenue growth grew by 40.8%, now sitting on 18.07B for the twelve trailing months.

Volatility

DISH Network’s last week, last month’s, and last quarter’s current volatility was a negative 4.82%, a negative 1.07%, and a positive 1.73%, respectively.

DISH Network’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.99% (last week), 2.24% (last month), and 1.73% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DISH Network’s stock is considered to be overbought (>=80).

DISH Network’s Stock Yearly Top and Bottom Value

DISH Network’s stock is valued at $37.86 at 07:34 EST, way under its 52-week high of $47.05 and way above its 52-week low of $27.44.

DISH Network’s Moving Average

DISH Network’s value is way below its 50-day moving average of $43.16 and way under its 200-day moving average of $42.84.

More news about DISH Network.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here